We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-4.84%
1 Year Est. Return
-12.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57M
AUM Growth
-$4.55M
Cap. Flow
-$5.82M
Cap. Flow %
-10.22%
Top 10 Hldgs %
51.56%
Holding
131
New
10
Increased
1
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
PMCB icon
PharmaCyte Biotech
PMCB
+$2.23M
2
PAVM icon
PAVmed
PAVM
+$2.01M
3
SLAI
SOLAI Ltd ADS
SLAI
+$191K
4
AYTU icon
AYTU BioPharma
AYTU
+$172K
5
LUCYW icon
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
+$98.9K

Top Sells

Rank Stock Value
1
MMV
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
+$1.78M
2
RICO
Agrico Acquisition Corp
RICO
+$668K
3
WARR
Warrior Technologies Acquisition Company
WARR
+$654K
4
GGGV
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
+$347K
5
MOBX icon
Mobix Labs
MOBX
+$126K

Sector Composition

Rank Sector Weight
1 Financials 49.52%
2 Healthcare 19.11%
3 Technology 6.46%
4 Consumer Discretionary 4.18%
5 Communication Services 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RICOW
126
DELISTED
Agrico Acquisition Corp Warrant
RICOW
– –
-25,000
Closed -$6K
EJFAW
127
DELISTED
EJF Acquisition Corp. Warrant
EJFAW
– –
-16,666
Closed -$7K
2 3 4 5
6

Similar funds

VVA
Vintage Ventures Advisors Herzliya, Israel $15.2M AUM 35.41% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
TAM
Toscafund Asset Management London, United Kingdom $15.6M AUM 12.56% 1-Year Est. Return
RCGI
Ribbit Capital GP IV Palo Alto, California $15.6M AUM 103.62% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
CAM
Connacht Asset Management New York $16.9M AUM 40.41% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return

Ayrton Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Ayrton Capital held 131 positions worth $57M, down 7.4% from $61.6M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Ayrton Capital withdrew a net $5.82M in Q3 2022, closing 12 positions and reducing 4 holdings. Its most notable exit was MultiMetaVerse Holdings Limited Class A Ordinary Share, an estimated $1.78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 54% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Ayrton Capital opened a new position in PAVmed worth $1.38M.

  • Ayrton Capital's largest Q3 2022 buy was PAVmed: 3,555 shares worth $1.38M.
  • Ayrton Capital added most to PharmaCyte Biotech in Q3 2022, an estimated $2.23M increase.
  • Ayrton Capital's biggest Q3 2022 reduction was Mobix Labs, cutting an estimated $126K.
  • Ayrton Capital fully exited MultiMetaVerse Holdings Limited Class A Ordinary Share in Q3 2022, selling an estimated $1.78M.
  • Ayrton Capital's ten largest holdings make up 52% of its $57M portfolio in Q3 2022.
  • Ayrton Capital opened 10 new positions and closed 12 in Q3 2022.
  • Ayrton Capital's portfolio value fell 7.4% quarter-over-quarter to $57M.

Based on Ayrton Capital's 13F filing for Q3 2022, filed 9 Nov 2022.